Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pseudomonas Aeruginosa”

211 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 211 results

Testing effectiveness (Phase 2)Study completedNCT01375049
What this trial is testing

Aztreonam Lysine for Pseudomonas Infection Eradication Study

Who this might be right for
Cystic Fibrosis
Gilead Sciences 105
Not applicableNot Yet RecruitingNCT07703644
What this trial is testing

Ceftazidime-Avibactam PK/PD and Resistance in Hematology Patients

Who this might be right for
Hematologic NeoplasmsGram-Negative Bacterial InfectionsPseudomonas Aeruginosa Infection+2 more
Sizhou Feng 60
Testing effectiveness (Phase 2)Study completedNCT01380808
What this trial is testing

Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Fudan University 100
Not applicableLooking for participantsNCT06738771
What this trial is testing

Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas InfectionsPseudomonas AeruginosaPrognosis+3 more
Centre Hospitalier Régional d'Orléans 600
Testing effectiveness (Phase 2)Study completedNCT00995033
What this trial is testing

Efficacy and Safety of NicVAX® Co-administered With Varenicline (Champix®)

Who this might be right for
Smoking BehaviorSmoking Lapse BehaviorSmoking Relapse Behavior
Maastricht University Medical Center 558
Not applicableLooking for participantsNCT06931002
What this trial is testing

A Rhinovirus Challenge Study to Investigate Exacerbations and Immune Responses in Bronchiectasis

Who this might be right for
Bronchiectasis AdultBronchiectasis With Acute ExacerbationBronchiectasis With Chronic Infection With Pseudomonas Aeruginosa+2 more
Imperial College London 54
Testing effectiveness (Phase 2)Study completedNCT05010577
What this trial is testing

Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection

Who this might be right for
Chronic Pseudomonas Aeruginosa InfectionCystic Fibrosis
BiomX, Inc. 43
Not applicableActive Not RecruitingNCT03947957
What this trial is testing

Microbial Biomarkers of EArly Pseudomonas Aeruginosa Colonization in CHildren With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
University Hospital, Brest 70
Testing effectiveness (Phase 2)UnknownNCT00752882
What this trial is testing

Ceftazidime Pharmacokinetic in Cerebrospinal Fluid Between Continuous and Intermittent Administration

Who this might be right for
Pseudomonas Aeruginosa Meningitis
University Hospital, Clermont-Ferrand 24
Not applicableStudy completedNCT05282082
What this trial is testing

Carbapenem-resistant Pseudomonas Aeruginosa: the SAMPAN Study.

Who this might be right for
Pseudomonas AeruginosaColonization, AsymptomaticNosocomial Infection
Erasmus Medical Center 2,105
Early research (Phase 1)Looking for participantsNCT07709494
What this trial is testing

A Phase 1a/1b Study to Investigate the Safety, Tolerability, Microbiological Response, and Pharmacokinetics of Inhaled Rev-56 in Adult Healthy Volunteers and Adult Non-cystic Fibrosis Bronchiectasis (NCFB) Patients With Chronic P. Aeruginosa

Who this might be right for
Healthy ParticipantsNon-cystic Fibrosis Bronchiectasis
Revagenix, Inc. 64
Testing effectiveness (Phase 2)UnknownNCT03669614
What this trial is testing

SAD and MAD of Inhaled AR-501 in Health Adults and P. Aeruginosa Infected Cystic Fibrosis Subjects

Who this might be right for
Cystic Fibrosis
Aridis Pharmaceuticals, Inc. 102
Early research (Phase 1)Study completedNCT06238856
What this trial is testing

Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa

Who this might be right for
Cystic Fibrosis
Insmed Incorporated 18
Testing effectiveness (Phase 2)Study completedNCT01465529
What this trial is testing

A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis

Who this might be right for
Cystic Fibrosis
AlgiPharma AS 26
Post-approval studies (Phase 4)UnknownNCT01044719
What this trial is testing

Duration of Antibiotics in Infective Exacerbations of Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Imperial College London 240
Not applicableStudy completedNCT00027183
What this trial is testing

Role of Toxins in Lung Infections Caused by Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas InfectionCystic Fibrosis
National Heart, Lung, and Blood Institute (NHLBI) 134
Large-scale testing (Phase 3)UnknownNCT03715322
What this trial is testing

Tobramycin in Bronchiectasis Colonized With Pseudmonas Aeruginosa

Who this might be right for
Bronchiectasis AdultPseudomonas Infections
Guangzhou Institute of Respiratory Disease 350
Not applicableLooking for participantsNCT05731427
What this trial is testing

Research on the Mechanism Affecting Progression of Bronchiectasis

Who this might be right for
Bronchiectasis
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 150
Not applicableStudy completedNCT00015756
What this trial is testing

Tissue Collection From People With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
National Heart, Lung, and Blood Institute (NHLBI) 100
Not applicableLooking for participantsNCT05017766
What this trial is testing

NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria

Who this might be right for
Antimicrobial Resistance (AMR)
University Hospital, Basel, Switzerland 8,000
Next Page